SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
31 hedge funds and large institutions have $5.18M invested in Sophiris Bio, Inc. in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% less capital invested
Capital invested by funds: $5.77M → $5.18M (-$596K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $235K
Holders
31
Holding in Top 10
1
Calls
–
Puts
$235K
Top Buyers
| 1 | +$448K | |
| 2 | +$61K | |
| 3 | +$39.3K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$33K |
| 5 |
JPMorgan Chase & Co
New York
|
+$16K |
Top Sellers
| 1 | -$491K | |
| 2 | -$434K | |
| 3 | -$100K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$90K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$51.9K |